Pharmafile Logo
Pharmafocus logo
Advanced Search
genentech_web

Ocrevus becomes first NICE-approved therapy on the NHS for primary progressive multiple sclerosis

May 9, 2019
Sales and Marketing Genentech, NHS, NICE, Ocrevus, UK

NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the …

News

Thousands of EU nurses and midwives leave NHS because of Brexit

May 9, 2019
Medical Communications NHS, health, hospitals, midwifes, nurses

Nearly 5,000 EU nurses and midwifes have left the NHS over the past two years. The number of EU nationals …

News
novartis_window

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

May 9, 2019
Business Services, Medical Communications, Sales and Marketing Novartis, Shire, Takeda, debt, pharma, xiidra

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal …

News
dupixentpackage

Sanofi’s Dupixent approved in Europe for severe asthma maintenance

May 9, 2019
Sales and Marketing Dupixent, EU, Europe, Sanofi, asthma, pharma

Sanofi has revealed that its interleukin-4 and interleukin-13 (IL-4 and IL-13) inhibitor Dupixent (dupilumab) has been awarded marketing approval by …

News
5204602349_c87b204860_z

Common diabetes drugs have been linked to a ‘flesh-eating’ genital infection

May 9, 2019
Medical Communications, Research and Development FG, diabetes, gangrene, health, necrotizing fasciitis

Patients taking some newer diabetes medications – SGLT2 inhibitors – have been warned that they may be at risk of …

News

Pfizer scores conditional European approval in ALK-positive lung cancer with Lorviqua

May 8, 2019
Research and Development Cancer, Europe, Lorviqua, NSCLC, Pfizer, lung cancer, pharma

Pfizer’s Lorviqua (lorlatinib), or Lorbrena as it is known in the US, Canada and Japan, has just been awarded conditional …

News
headquarters_3_web

Eli Lilly’s Emgality shows positive Phase 3 results in treatment of migraine

May 8, 2019
Research and Development Eli Lilly, Emgality, cluster headache, headache, migraine, pharma

Eli Lilly has announced positive results from the Phase 3 EVOLVE-1 and EVOLVE-2 trials looking into Emgality (galcanezumab-gnlm) for the …

News
astrazeneca-sign

AZ ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia

May 8, 2019
Research and Development AstraZeneca, Calquence, pharma

AstraZeneca has unveiled new Phase 3 data on the efficacy of its Bruton tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) in …

News

US prescription drugs most expensive in world, analysis shows

May 8, 2019
Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …

News

Number of GPs in decline for first time in 50 years

May 8, 2019
Manufacturing and Production, Research and Development GP, NHS, pharma, public health

The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall …

News
mohammed_dar

Mohammed Dar becomes third MedImmune exec to join Immunocore

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …

Appointment
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

Appointment
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …

Appointment

Will mobile phones save the NHS?

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

Feature
shutterstock_159488225

Astellas and Cytokinetics’ reldesemtiv falls short at Phase 2 in ALS

May 7, 2019
Manufacturing and Production, Sales and Marketing Astellas, als, amyotrophic lateral sclerosis, cytokinetics, pharma

Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell …

News

Lundbeck acquire Abide Therapeutics in deal worth $400 million

May 7, 2019
Manufacturing and Production, Sales and Marketing Abide Therapeutics, Lundbeck, endocannabinoid system, neuropathic pain, tourette's

Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million. …

News
gwpharma

GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial

May 7, 2019
Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc

GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …

News

FDA approves first two drugs for transthyretin amyloid cardiomyopathy

May 7, 2019
Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma

The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …

News
450px-official_portrait_of_matt_hancock_crop_2

Health Secretary Matt Hancock says he will not rule out ‘compulsory vaccination’

May 7, 2019
Manufacturing and Production, Sales and Marketing Matt Hancock, infectious diseases, pharma, public health, vaccines

Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …

News
shutterstock_232245868

GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3

May 3, 2019
Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026